BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 4894464)

  • 1. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.
    Bircher J; Haemmerli UP; Scollo-Lavizzari G; Hoffmann K
    Am J Med; 1971 Aug; 51(2):148-59. PubMed ID: 5095524
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic porto-systemic encephalopathy with lactulose].
    Bircher J; Scollo-Lavizzari G; Hoffmann K; Haemmerli UP
    Schweiz Med Wochenschr; 1969 Apr; 99(16):584. PubMed ID: 5768016
    [No Abstract]   [Full Text] [Related]  

  • 8. Wrong idea, good results (the lactulose story).
    Haemmerli UP; Bircher J
    N Engl J Med; 1969 Aug; 281(8):441-2. PubMed ID: 5797190
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lactulose in the treatment of chronic portosystemic encephalopathies].
    Seidlová V
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic hepatic encephalopathy with lactulose.
    Fung WP; Khoo OT
    Med J Aust; 1968 Jul; 2(4):160-3. PubMed ID: 5670884
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lactulose in the therapy of porto-systemic encephalopathy].
    Almici C; Inzoli MR; Poloni AE; Zambruni A
    Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
    [No Abstract]   [Full Text] [Related]  

  • 12. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
    Atterbury CE; Maddrey WC; Conn HO
    Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol.
    Rodgers JB; Kiley JE; Balint JA
    Am J Gastroenterol; 1973 Nov; 60(5):459-65. PubMed ID: 4587191
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic portal-systemic encephalopathy with lactulose (synthetic disaccharide: one molecule of galactose and one of fructose)].
    Cassi E; Sala E; Beretta R; Colombo A; Cova L; Ezechieli S; Malacco E; Massarotti G; Pagani C
    Clin Ter; 1972 Dec; 63(6):531-56. PubMed ID: 4656204
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lactulose treatment in 80 cirrhotics: basic considerations and results].
    Müting D; Ordnung W; Arfeen N; Barth V; Reikowski J
    Dtsch Med Wochenschr; 1972 Aug; 97(34):1238-43. PubMed ID: 4625907
    [No Abstract]   [Full Text] [Related]  

  • 17. Lactulose: comments on mechanism of action and current status.
    Conn HO
    Conn Med; 1972 Oct; 36(10):582-6. PubMed ID: 5086118
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 19. Lactulose treatment of hepatic encephalopathy in outpatients.
    Brown H; Trey C; McDermott WV
    Arch Surg; 1971 Jan; 102(1):25-7. PubMed ID: 5538764
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.
    Uribe M; Farca A; Márquez MA; Garcĭa-Ramos G; Guevara L
    Gastroenterology; 1979 Jun; 76(6):1347-51. PubMed ID: 374177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.